Press release
Influenza Vaccine Market is projected to grow to US$ 13.75 billion by 2032 | Sanofi, GSK plc, SINOVAC, Zydus Cadila Healthcare, CSL, Viatris Inc
The Influenza Vaccine market was valued at US$ 8.41 billion in 2024 and is projected to grow to approximately US$ 13.75 billion by 2032, with a compound annual growth rate (CAGR) of 6.5% during the forecast period from 2025 to 2032.Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/influenza-vaccines-market?sg
Influenza Vaccine Market Key Drivers:
• Rising Global Influenza Burden
The seasonal nature of influenza, with millions affected annually, creates consistent demand for vaccines. The risk of pandemic strains emerging further reinforces the need for mass immunization programs worldwide.
• Government Immunization Initiatives
National health agencies and global organizations actively promote influenza vaccination, particularly for high-risk groups. Public sector procurement and vaccination mandates in schools, hospitals, and aged-care facilities are major growth contributors.
• Advancements in Vaccine Technology
Development of quadrivalent, cell-based, and recombinant influenza vaccines is improving efficacy and production timelines. These innovations are expanding product offerings and strengthening market competitiveness.
• Aging Population and Comorbidities
The growing elderly population, which is more susceptible to flu complications, is driving demand. Additionally, people with chronic conditions such as diabetes or cardiovascular disease represent a key target demographic.
• Increasing Awareness and Education Campaigns
Public health messaging and media campaigns highlighting the importance of annual flu vaccination are influencing consumer behavior, especially in urban populations.
Influenza Vaccines Market Segments:
• By Product Type (Inactivated, Live Attenuated)
• By Category (Quadrivalent, Trivalent)
• By Route of Administration (Injection, Nasal Spray)
• By Age Group (Pediatric, Adults)
• By End-User (Hospitals, Specialty Clinics, Others)
Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/influenza-vaccines-market?sg
Influenza Vaccines Market: Geographical Share:
• North America
North America holds the largest share of the global influenza vaccines market, driven by strong government immunization programs, high healthcare spending, and robust awareness campaigns. The U.S. CDC's annual flu vaccination recommendations, coupled with significant investments in vaccine R&D and pandemic preparedness, further boost regional demand.
• Europe
Europe follows closely due to widespread vaccination coverage, strong public health infrastructure, and supportive regulatory policies. Countries like the UK, Germany, and France maintain high seasonal influenza vaccination rates among vulnerable populations such as the elderly and those with chronic illnesses.
• Asia-Pacific
The Asia-Pacific region is experiencing rapid growth, fueled by increasing population density, rising healthcare awareness, and improved access to vaccines. Government-led immunization drives in countries like China, India, and Japan are expanding market penetration, especially amid concerns over potential outbreaks and zoonotic influenza strains.
• Latin America and Middle East & Africa
These regions are witnessing moderate growth. Efforts by public health agencies and international collaborations are enhancing access to flu vaccines. However, limited infrastructure and variable vaccine coverage remain key challenges in certain countries.
Influenza Vaccine Market Key Players: Sanofi, GSK plc., Pfizer Inc., AstraZeneca, CSL, Viatris Inc. (Mylan), Bharat Biotech., SINOVAC, Zydus Cadila Healthcare Limited, and Serum Institute of India Pvt. Ltd.
Request for FREE Trial Access: https://www.datamintelligence.com/reports-subscription?sg
New product launches & approvals:
FluMist nasal spray, produced by AstraZeneca/MedImmune, received FDA approval in September 2024 for self‐ or caregiver‐administration at home for people up to age 49. Distribution via online pharmacies begins fall 2025.
Arcturus Therapeutics initiated a Phase 1 trial (called LUNAR‐H5N1 or ARCT‐2304) for its self‐amplifying mRNA H5N1 pandemic influenza vaccine. First participants were dosed in December 2024; interim data is expected in the second half of 2025.
Major M&A deals and acquisitions:
In July 2025, Sanofi announced acquisition of UK bioteche firm Vicebio for up to US $1.6 billion. The deal brings early-stage vaccine candidates (including combination RSV/HMPV formulations) and "molecular clamp" technology that supports standard‐refrigeration storage. Completion is expected in Q4 2025.
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Influenza Vaccine Market is projected to grow to US$ 13.75 billion by 2032 | Sanofi, GSK plc, SINOVAC, Zydus Cadila Healthcare, CSL, Viatris Inc here
News-ID: 4124086 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Japan Single-Use Bioprocessing Products Market: Thermo Fisher, Sartorius & Cytiv …
Market Size and Forecast:
Japan Single-Use Bioprocessing Products Market is expected to reach growth at a Significant CAGR during the forecast period 2024-2031
The Japan Single-Use Bioprocessing Products Market Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of…
United States Pharmaceutical Packaging Market to Grow at 9.5% CAGR, Driven by Re …
The global Pharmaceutical Packaging Market is growing at a CAGR of 9.5% during the forecast period 2024-2031, according to DataM Intelligence.
United States: Recent Industry Developments
✅ In October 2025, Amcor PLC launched a new series of recyclable cold-chain packaging solutions for biologic drugs, enhancing sustainability in temperature-sensitive shipments.
✅ In October 2025, West Pharmaceutical Services introduced a novel smart vial system with integrated sensors for real-time temperature and tamper monitoring.
✅…
United States Optical Imaging Market to Grow at 12.4% CAGR, Reaching USD 4.0 bil …
The global Optical Imaging Market reached USD 1.6 billion in 2022 and is projected to reach USD 4.0 billion by 2031, growing at a CAGR of 12.4% during the forecast period 2024-2031, according to DataM Intelligence.
United States: Recent Industry Developments
✅ In October 2025, Canon U.S.A. received FDA clearance for its next-generation optical coherence tomography (OCT) system with AI-enhanced diagnostic capabilities for ophthalmology.
✅ In October 2025, Abbott Laboratories…
United States Precious Metal Market to Grow at 5.2% CAGR, Led by Newmont Corpora …
The global Precious Metal Market reached USD 209.4 billion in 2023 and is projected to reach USD 300.3 million by 2031, growing at a CAGR of 5.2% during the forecast period 2024-2031, according to DataM Intelligence.
United States: Recent Industry Developments
✅ In October 2025, Newmont Corporation announced the expansion of its Nevada Gold Mines complex, increasing gold production capacity by 15% through advanced extraction technologies.
✅ In October 2025, The…
More Releases for Influenza
Multivalent Influenza Vaccines Market Advancing Influenza Prevention Strategies …
The "Multivalent Influenza Vaccines Market" research report represents major insights on the current growth dynamics as well as the primary revenue generation elements that are available in the Multivalent Influenza Vaccines industry along with various other factors over the predicted period 2024-2030. The report on the Multivalent Influenza Vaccines market is focusing on a series of parameters including top manufacturing strategies, industry share, prime opportunities, industrial channels, profit margin, etc.…
Influenza Diagnostics Market - Rapid Detection, Effective Protection: Influenza …
Newark, New Castle, USA: The "Influenza Diagnostics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Influenza Diagnostics Market: https://www.growthplusreports.com/report/influenza-diagnostics-market/8780
This latest report researches the industry structure, sales, revenue,…
Influenza Medication Market - Fight off the influenza virus with effective and r …
Newark, New Castle, USA: The "Influenza Medication Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Influenza Medication Market: https://www.growthplusreports.com/report/influenza-medication-market/7859
This latest report researches the industry structure, sales, revenue,…
Influenza Medication Market - Revolutionizing Flu Treatment: Innovating Advanced …
Newark, New Castle, USA - new report, titled Influenza Medication Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Influenza Medication market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Influenza Medication market. The report offers an overview of the market, which…
Influenza Vaccines Market - Empowering Strength, Nurturing Immunity: Innovating …
Newark, New Castle, USA - new report, titled Influenza Vaccines Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Influenza Vaccines market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Influenza Vaccines market. The report offers an overview of the market, which…
H1N1 Influenza (Swine Influenza) Market to Witness Growth by 2032, Estimates Del …
DelveInsight's "H1N1 Influenza (Swine Influenza) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of H1N1 Influenza (Swine Influenza), historical and forecasted epidemiology as well as the H1N1 Influenza (Swine Influenza) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The H1N1 Influenza (Swine Influenza) market report provides current treatment practices, emerging drugs, the market share of the individual therapies,…
